rs818708

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_000031.6(ALAD):​c.*471C>T variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.534 in 203,248 control chromosomes in the GnomAD database, including 31,703 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.56 ( 25945 hom., cov: 31)
Exomes 𝑓: 0.45 ( 5758 hom. )

Consequence

ALAD
NM_000031.6 3_prime_UTR

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: 0.0670

Publications

23 publications found
Variant links:
Genes affected
ALAD (HGNC:395): (aminolevulinate dehydratase) The ALAD enzyme is composed of 8 identical subunits and catalyzes the condensation of 2 molecules of delta-aminolevulinate to form porphobilinogen (a precursor of heme, cytochromes and other hemoproteins). ALAD catalyzes the second step in the porphyrin and heme biosynthetic pathway; zinc is essential for enzymatic activity. ALAD enzymatic activity is inhibited by lead and a defect in the ALAD structural gene can cause increased sensitivity to lead poisoning and acute hepatic porphyria. Alternative splicing of this gene results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Dec 2015]
ALAD Gene-Disease associations (from GenCC):
  • porphyria due to ALA dehydratase deficiency
    Inheritance: AR Classification: STRONG, MODERATE, SUPPORTIVE, LIMITED Submitted by: Ambry Genetics, Genomics England PanelApp, Orphanet, Labcorp Genetics (formerly Invitae), G2P, ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.84).
BP6
Variant 9-113387829-G-A is Benign according to our data. Variant chr9-113387829-G-A is described in ClinVar as Benign. ClinVar VariationId is 364632.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.803 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ALADNM_000031.6 linkc.*471C>T 3_prime_UTR_variant Exon 12 of 12 ENST00000409155.8 NP_000022.3 P13716-1A0A140VJL9Q6ZMU0

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ALADENST00000409155.8 linkc.*471C>T 3_prime_UTR_variant Exon 12 of 12 1 NM_000031.6 ENSP00000386284.3 P13716-1
ALADENST00000482847.5 linkn.1737C>T non_coding_transcript_exon_variant Exon 12 of 12 2

Frequencies

GnomAD3 genomes
AF:
0.561
AC:
85202
AN:
151894
Hom.:
25895
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.810
Gnomad AMI
AF:
0.465
Gnomad AMR
AF:
0.491
Gnomad ASJ
AF:
0.510
Gnomad EAS
AF:
0.621
Gnomad SAS
AF:
0.469
Gnomad FIN
AF:
0.402
Gnomad MID
AF:
0.525
Gnomad NFE
AF:
0.456
Gnomad OTH
AF:
0.556
GnomAD4 exome
AF:
0.454
AC:
23258
AN:
51236
Hom.:
5758
Cov.:
0
AF XY:
0.457
AC XY:
12183
AN XY:
26684
show subpopulations
African (AFR)
AF:
0.818
AC:
1565
AN:
1914
American (AMR)
AF:
0.447
AC:
1778
AN:
3974
Ashkenazi Jewish (ASJ)
AF:
0.507
AC:
529
AN:
1044
East Asian (EAS)
AF:
0.608
AC:
1985
AN:
3266
South Asian (SAS)
AF:
0.455
AC:
3128
AN:
6876
European-Finnish (FIN)
AF:
0.391
AC:
659
AN:
1686
Middle Eastern (MID)
AF:
0.531
AC:
86
AN:
162
European-Non Finnish (NFE)
AF:
0.417
AC:
12354
AN:
29644
Other (OTH)
AF:
0.440
AC:
1174
AN:
2670
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.506
Heterozygous variant carriers
0
590
1180
1770
2360
2950
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
198
396
594
792
990
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.561
AC:
85297
AN:
152012
Hom.:
25945
Cov.:
31
AF XY:
0.557
AC XY:
41356
AN XY:
74300
show subpopulations
African (AFR)
AF:
0.810
AC:
33612
AN:
41488
American (AMR)
AF:
0.491
AC:
7492
AN:
15256
Ashkenazi Jewish (ASJ)
AF:
0.510
AC:
1768
AN:
3470
East Asian (EAS)
AF:
0.621
AC:
3213
AN:
5176
South Asian (SAS)
AF:
0.468
AC:
2252
AN:
4808
European-Finnish (FIN)
AF:
0.402
AC:
4245
AN:
10552
Middle Eastern (MID)
AF:
0.510
AC:
150
AN:
294
European-Non Finnish (NFE)
AF:
0.456
AC:
30982
AN:
67954
Other (OTH)
AF:
0.551
AC:
1162
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
1718
3436
5153
6871
8589
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
704
1408
2112
2816
3520
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.486
Hom.:
36793
Bravo
AF:
0.577
Asia WGS
AF:
0.512
AC:
1782
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Porphobilinogen synthase deficiency Benign:1
Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.84
CADD
Benign
2.9
DANN
Benign
0.69
PhyloP100
0.067
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.0
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs818708; hg19: chr9-116150109; API